Table 1.
Patient and treatment cycle characteristics.
| GV+ | GV− | p Value | |
|---|---|---|---|
| Number of patients | 29 | 31 | |
| Age (mean ± SD) | 36.4 ± 4.8 | 35.4 ± 4.4 | 0.45 |
| ICSI (%) | 24 (82.8) | 22 (71) | 0.22 |
| Total embryo transfer events | 46 | 40 | |
| Total embryos transferred (%) | 51 (68.9) | 43 (57.3) | 0.1 |
| Total embryos used (%) | 55 (74.3) | 52 (69.3) | 0.25 |
| Number of embryos per transfer (mean ± SD) | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.6 |
| Single embryo transfers (%) | 41 (89.1) | 37 (92.5) | 0.43 |
| Blastocyst-stage transfers (%) | 40 (78.4) | 36 (83.7) | 0.44 |
| Complete embryo utilisation (%) | 23 (79.3) | 23 (74.2) | 0.44 |
GV+: Patients with germinal vesicle-stage oocytes; GV−: Patients without germinal vesicle-stage oocytes.